Drug Treatment of Cystic Fibrosis and Breastfeeding

Abstract

Get full access to this article

View all access options for this article.

References

Zhang

. The Cystic-Fibrosis Breakthrough That Changed Everything. The Atlantic; March 7, 2024. Available from: https://www.theatlantic.com/magazine/archive/2024/04/cystic-fibrosis-trikafta-breakthrough-treatment/677471/?utm_medium=cr&utm_source=email&utm_content=automated&utm_campaign=author_pilot_sarah_zhang

Calthorpe

, Rosenfeld

, Goss

, et al. Pancreatic enzyme prescription following ivacaftor licensing: A retrospective analysis of the US and UK cystic fibrosis registries. J Cyst Fibros, 2024; 23(4):746–753; doi: 10.1016/j.jcf.2024.01.011

Ramsey

, Galante

. Pancreas and pancreatitis: Exocrine pancreatic insufficiency. Pediatr Pulmonol, 2024; 59(Suppl 1):S44–S52; doi: 10.1002/ppul.27013

Anderson

. Treating hyperlipidemia during breastfeeding. Breastfeed Med, 2020; 15(4):189–190; doi: 10.1089/bfm.2019.0300

Campbell

, Huseman

, Krutsch

, et al. Minimal transfer of atorvastatin and its metabolites in human milk: A case series. Breastfeed Med, 2024; 19(11):889–894; doi: 10.1089/bfm.2024.0258